DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,879,499 | +42.6% | 35,790 | +37.9% | 0.17% | +52.3% |
| Q2 2023 | $6,226,800 | -4.7% | 25,945 | +0.1% | 0.11% | -9.8% |
| Q1 2023 | $6,531,113 | -3.9% | 25,913 | +1.2% | 0.12% | -4.7% |
| Q4 2022 | $6,795,017 | +2.1% | 25,601 | -0.6% | 0.13% | -5.1% |
| Q3 2022 | $6,654,000 | -2.0% | 25,761 | -3.8% | 0.14% | +9.7% |
| Q2 2022 | $6,787,000 | -14.8% | 26,771 | -1.4% | 0.12% | +3.3% |
| Q1 2022 | $7,965,000 | -12.4% | 27,153 | -1.7% | 0.12% | -4.0% |
| Q4 2021 | $9,091,000 | +8.0% | 27,631 | -0.1% | 0.12% | 0.0% |
| Q3 2021 | $8,417,000 | +10.0% | 27,646 | -3.0% | 0.12% | +12.6% |
| Q2 2021 | $7,649,000 | +17.2% | 28,504 | -1.7% | 0.11% | +11.0% |
| Q1 2021 | $6,524,000 | +2.1% | 28,984 | +0.8% | 0.10% | -6.5% |
| Q4 2020 | $6,387,000 | +3.2% | 28,754 | +0.1% | 0.11% | -9.3% |
| Q3 2020 | $6,186,000 | +12.1% | 28,729 | -8.0% | 0.12% | +2.6% |
| Q2 2020 | $5,519,000 | +19.1% | 31,213 | -6.7% | 0.12% | 0.0% |
| Q1 2020 | $4,632,000 | -11.8% | 33,467 | -2.2% | 0.12% | +49.4% |
| Q4 2019 | $5,252,000 | +5.7% | 34,220 | -0.6% | 0.08% | +14.9% |
| Q3 2019 | $4,971,000 | +4.5% | 34,420 | +3.4% | 0.07% | +8.1% |
| Q2 2019 | $4,757,000 | +6.5% | 33,285 | -1.6% | 0.06% | +3.3% |
| Q1 2019 | $4,465,000 | +29.2% | 33,820 | +0.9% | 0.06% | +15.4% |
| Q4 2018 | $3,457,000 | -5.1% | 33,520 | 0.0% | 0.05% | +13.0% |
| Q3 2018 | $3,642,000 | +11.1% | 33,520 | +0.9% | 0.05% | +9.5% |
| Q2 2018 | $3,278,000 | +0.2% | 33,215 | -0.6% | 0.04% | 0.0% |
| Q1 2018 | $3,272,000 | +6.7% | 33,415 | +1.1% | 0.04% | +20.0% |
| Q4 2017 | $3,067,000 | +6.3% | 33,040 | -1.7% | 0.04% | +6.1% |
| Q3 2017 | $2,884,000 | -7.9% | 33,620 | -9.4% | 0.03% | -13.2% |
| Q2 2017 | $3,130,000 | -1.9% | 37,090 | -0.6% | 0.04% | -2.6% |
| Q1 2017 | $3,190,000 | -24.4% | 37,296 | -31.2% | 0.04% | -27.8% |
| Q4 2016 | $4,220,000 | -2.9% | 54,220 | -2.2% | 0.05% | +3.8% |
| Q3 2016 | $4,345,000 | -61.4% | 55,430 | -50.3% | 0.05% | -25.7% |
| Q2 2016 | $11,258,000 | +118.1% | 111,472 | +104.8% | 0.07% | +2.9% |
| Q1 2016 | $5,162,000 | +6.0% | 54,419 | +3.8% | 0.07% | +3.0% |
| Q4 2015 | $4,868,000 | +23.9% | 52,407 | +13.7% | 0.07% | +24.5% |
| Q3 2015 | $3,928,000 | -1.3% | 46,097 | -0.9% | 0.05% | +12.8% |
| Q2 2015 | $3,981,000 | +197.3% | 46,513 | +163.9% | 0.05% | +213.3% |
| Q3 2014 | $1,339,000 | -33.1% | 17,625 | -30.7% | 0.02% | -21.1% |
| Q2 2014 | $2,002,000 | +111.4% | 25,430 | +101.3% | 0.02% | +58.3% |
| Q1 2014 | $947,000 | +0.3% | 12,630 | +3.3% | 0.01% | -7.7% |
| Q4 2013 | $944,000 | +13.1% | 12,230 | +1.5% | 0.01% | +30.0% |
| Q3 2013 | $835,000 | -12.8% | 12,050 | -20.4% | 0.01% | -23.1% |
| Q2 2013 | $958,000 | – | 15,140 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |